1. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis
- Author
-
Li, Y, Wang, X, Blau, DM, Caballero, MT, Feikin, DR, Gill, CJ, Madhi, SA, Omer, SB, Simoes, EAF, Campbell, H, Pariente, AB, Bardach, D, Bassat, Q, Casalegno, J-S, Chakhunashvili, G, Crawford, N, Danilenko, D, Ha Do, LA, Echavarria, M, Gentile, A, Gordon, A, Heikkinen, T, Huang, QS, Jullien, S, Krishnan, A, Lopez, EL, Markic, J, Mira-Iglesias, A, Moore, HC, Moyes, J, Mwananyanda, L, Nokes, DJ, Noordeen, F, Obodai, E, Palani, N, Romero, C, Salimi, V, Satav, A, Seo, E, Shchomak, Z, Singleton, R, Stolyarov, K, Stoszek, SK, von Gottberg, A, Wurzel, D, Yoshida, L-M, Yung, CF, Zar, HJ, Nair, H, Li, Y, Wang, X, Blau, DM, Caballero, MT, Feikin, DR, Gill, CJ, Madhi, SA, Omer, SB, Simoes, EAF, Campbell, H, Pariente, AB, Bardach, D, Bassat, Q, Casalegno, J-S, Chakhunashvili, G, Crawford, N, Danilenko, D, Ha Do, LA, Echavarria, M, Gentile, A, Gordon, A, Heikkinen, T, Huang, QS, Jullien, S, Krishnan, A, Lopez, EL, Markic, J, Mira-Iglesias, A, Moore, HC, Moyes, J, Mwananyanda, L, Nokes, DJ, Noordeen, F, Obodai, E, Palani, N, Romero, C, Salimi, V, Satav, A, Seo, E, Shchomak, Z, Singleton, R, Stolyarov, K, Stoszek, SK, von Gottberg, A, Wurzel, D, Yoshida, L-M, Yung, CF, Zar, HJ, and Nair, H
- Abstract
BACKGROUND: Respiratory syncytial virus (RSV) is the most common cause of acute lower respiratory infection in young children. We previously estimated that in 2015, 33·1 million episodes of RSV-associated acute lower respiratory infection occurred in children aged 0-60 months, resulting in a total of 118 200 deaths worldwide. Since then, several community surveillance studies have been done to obtain a more precise estimation of RSV associated community deaths. We aimed to update RSV-associated acute lower respiratory infection morbidity and mortality at global, regional, and national levels in children aged 0-60 months for 2019, with focus on overall mortality and narrower infant age groups that are targeted by RSV prophylactics in development. METHODS: In this systematic analysis, we expanded our global RSV disease burden dataset by obtaining new data from an updated search for papers published between Jan 1, 2017, and Dec 31, 2020, from MEDLINE, Embase, Global Health, CINAHL, Web of Science, LILACS, OpenGrey, CNKI, Wanfang, and ChongqingVIP. We also included unpublished data from RSV GEN collaborators. Eligible studies reported data for children aged 0-60 months with RSV as primary infection with acute lower respiratory infection in community settings, or acute lower respiratory infection necessitating hospital admission; reported data for at least 12 consecutive months, except for in-hospital case fatality ratio (CFR) or for where RSV seasonality is well-defined; and reported incidence rate, hospital admission rate, RSV positive proportion in acute lower respiratory infection hospital admission, or in-hospital CFR. Studies were excluded if case definition was not clearly defined or not consistently applied, RSV infection was not laboratory confirmed or based on serology alone, or if the report included fewer than 50 cases of acute lower respiratory infection. We applied a generalised linear mixed-effects model (GLMM) to estimate RSV-associated acute lower respir
- Published
- 2022